BioNexus Gene Lab Corp (BGLC) stock: key figures, P/E, revenue and dividend
Health Care · Malaysia · ISIN US0906283066
BioNexus Gene Lab Corp financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 7.42 m USD |
| Gross profit | 1.09 m USD |
| Operating income | -2.97 m USD |
| EBIT | -2.98 m USD |
| Net income | -2.98 m USD |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About BioNexus Gene Lab Corp
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
More stocks
- My City Builders, Inc. (MYCB)
- Dror Ortho-Design, Inc. (DROR)
- GBT Technologies Inc. (GTCH)
- Nuwellis, Inc. (NUWE)
- CV Sciences, Inc. (CVSI)
- PSQ Holdings, Inc. (PSQH)
- Iveda Solutions, Inc. (IVDA)
- ADAMANT DRI PROCESSING & MINERALS GROUP (ADMG)
- RELIABILITY INC (RLBY)
- Co-Diagnostics, Inc. (CODX)
- 20/20 Biolabs, Inc. (AIDX)
- BioAtla, Inc. (BCAB)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.